Creative Biolabs Unveils Cell-Surface Engineering Technology Called CellFace™

Creative Biolabs introduces an innovative launch of CellFace™ conjugation technology, entering a new era in cell surface engineering with immense therapeutic promise, particularly in the realm of cancer immunotherapy.

New York, USA – February 23, 2024 – The integration of antibodies with cell surfaces marks a pivotal leap forward in cell therapy. This technology not only streamlines the process of functionalizing cell surfaces but also overcomes certain limitations associated with conventional methods. Traditional gene modification techniques, such as CAR-T, often entail permanent alterations to cells, potentially constraining their applicability.

“In contrast, cell-antibody conjugate enables researchers to modify cell surfaces as necessary without permanently altering their genomes. This transient modification feature offers greater adaptability and control for tailored therapies, thereby enhancing the effectiveness of CAR-T cell therapy,” elucidated a scientist at Creative Biolabs.

Creative Biolabs provides technology developers with an array of cell lines, a diverse assortment of antibodies and proteins, and comprehensive characterization services for cell antibody conjugates. “We offer meticulously validated cell lines spanning various disease states and sources, including cancer cell lines, immune cell lines, stem cells, and more, ensuring they are free from any harmful pathogens, bacteria, or viruses. This level of precision caters to the diverse developmental needs of researchers.”

“On the CellFace™ platform, Creative Biolabs is dedicated to offering researchers a wide range of choices or personalized services for various biomolecules utilized in binding to cell surfaces, encompassing proteins and antibodies.” Notably, besides antibody forms like Fab and bispecific antibodies, Creative Biolabs also provides other proteins such as antigens, hormones, growth factors, vitamins, etc., which firmly bind to cell surfaces while preserving cell viability.

This platform is distinguished by its one-stop characteristics. In addition to the essential technologies and material provisions mentioned earlier, Creative Biolabs also offers characterization services for cell-antibody conjugate products, including but not limited to:

* ADCC analysis

* Antibody-antigen binding analysis

* Antibody labeling efficiency analysis

“Cell surface engineering technology can be realized through various methods, including chemical modification, biological modification, and physical modification, and its advancement has opened up extensive applications across various domains, including drug delivery, cell therapy, biosensing, etc. Apart from providing technical and experiential support during the developmental phase, Creative Biolabs also delivers cell-antibody conjugate products.”

For cell-antibody conjugate technology services, please visit

About Creative Biolabs

As a leading provider of antibody-related products and services to researchers, Creative Biolabs has been at the forefront, offering CellFace™ conjugation technology characterized by its agility and simplicity, facilitating its adoption in laboratory settings. Scientists at Creative Biolabs offer expert guidance tailored to the client’s research objectives and requirements, aiding clients in determining the most suitable solutions.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States